{
    "2021-06-29": [
        [
            {
                "time": "2023-07-12",
                "original_text": "健帆生物(300529.SZ)：10亿元可转债将于7月12日起在深交所挂牌交易",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "可转债",
                        "挂牌交易",
                        "深交易所"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-07-10",
                "original_text": "健帆生物(300529.SZ)董事兼副总经理曾凯减持13.4万股 减持计划完成",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "曾凯",
                        "减持",
                        "股份"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-07-10",
                "original_text": "健帆生物：董事兼副总经理曾凯减持计划实施完毕",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "曾凯",
                        "减持计划"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-07-11",
                "original_text": "健帆生物：高管曾凯累计减持0.02%股份 减持股份",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "曾凯",
                        "减持",
                        "股份"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-07-09",
                "original_text": "健帆生物：红外线治疗仪取得医疗器械注册证",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "红外线治疗仪",
                        "医疗器械注册证"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}